View of Steven Johnson Syndrome Induced by Pembrolizumab and Capecitabine: A Case of a 71-Year-Old Woman with Esophageal Metastatic Squamous Carcinoma Treated with Double Oral Chemotherapy

Return to Article Details Steven Johnson Syndrome Induced by Pembrolizumab and Capecitabine: A Case of a 71-Year-Old Woman with Esophageal Metastatic Squamous Carcinoma Treated with Double Oral Chemotherapy Download Download PDF